Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Not Confirmed
Not Confirmed
29-31 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Industry Trade Show
Not Confirmed
29-31 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
10 Jul 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/revolution-lines-iambics-ai-platforms-25m-drug-discovery-deal
30 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/30/3107412/0/en/Revolution-Medicines-and-Summit-Therapeutics-Enter-into-Clinical-Collaboration-to-Evaluate-Combinations-of-Three-RAS-ON-Inhibitors-with-Ivonescimab-in-RAS-Mutant-Tumors.html
25 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/24/3104115/0/en/Royalty-Pharma-and-Revolution-Medicines-Enter-Into-Funding-Agreements-for-Up-to-2-Billion.html
23 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/23/3103444/0/en/Revolution-Medicines-Announces-FDA-Breakthrough-Therapy-Designation-for-Daraxonrasib-in-Previously-Treated-Metastatic-Pancreatic-Cancer-with-KRAS-G12-Mutations.html
14 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/14/3081088/0/en/Revolution-Medicines-Announces-First-Patient-Dosed-in-Phase-3-Clinical-Trial-Evaluating-Daraxonrasib-in-Previously-Treated-Patients-with-RAS-Mutant-Non-Small-Cell-Lung-Cancer.html
07 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/07/3076545/0/en/Revolution-Medicines-Reports-First-Quarter-2025-Financial-Results-and-Update-on-Corporate-Progress.html
ABOUT THIS PAGE